Is having a lobar intracerebral hemorrhage linked to higher readmission or dementia risk?

Lobar intracerebral hemorrhage (ICH) is a type of stroke where bleeding occurs in the outer parts of the brain. Research suggests that the location of the bleeding matters for long-term outcomes. A large study from Scotland found that people with lobar ICH had higher rates of hospital readmission within one year and a greater risk of developing dementia compared to those with deep ICH ⁵. This link may be partly due to an underlying condition called cerebral amyloid angiopathy (CAA), which is common in older adults and often causes lobar bleeding ⁹.

What the research says

A 2023 study from Scotland used natural language processing to analyze brain scans of over 64,000 people with stroke, including 1,456 with lobar ICH and 1,814 with deep ICH ⁵. The researchers found that the absolute rate of 1-year hospital readmission was higher for lobar ICH (4.9%) compared to deep ICH ⁵. Additionally, lobar ICH was associated with a higher risk of developing dementia over time ⁵. This study highlights that lobar location itself is a risk factor for worse outcomes.

Another study from Denmark, published in JAMA Network Open in 2023, followed 2,819 people with first-ever spontaneous ICH and compared those with lobar versus nonlobar bleeding ¹⁰. The researchers found that lobar ICH survivors had a higher risk of major cardiovascular events, including recurrent ICH and ischemic stroke, compared to those with nonlobar ICH ¹⁰. This suggests that the location of the initial bleed influences future health risks.

The link between lobar ICH and dementia may be explained by cerebral amyloid angiopathy (CAA), a condition where amyloid protein builds up in the walls of brain blood vessels, making them fragile and prone to bleeding ⁹. CAA is strongly associated with lobar ICH and is also linked to Alzheimer's disease, a common cause of dementia ⁹¹¹. A 2024 genetic study found that certain inflammatory pathways (IL-6 signaling) may affect the risk of both Alzheimer's disease and lobar ICH, suggesting shared biological mechanisms ¹¹.

What to ask your doctor

• What is my risk of readmission or dementia after a lobar ICH, and how can we monitor for these outcomes?
• Should I be evaluated for cerebral amyloid angiopathy (CAA) given my lobar ICH location?
• Are there any lifestyle changes or medications that could lower my risk of recurrent stroke or dementia?
• How often should I have follow-up appointments or brain imaging after a lobar ICH?
• What signs of cognitive decline should I watch for, and when should I seek medical help?